GL1X · GenesisL1 explorer

MolNFT v1 · #171142 · protein

Crystal structure of M. tuberculosis inha inhibited by SKTS1

6YUU · Enoyl-[acyl-carrier-protein] reductase [NADH]: “Crystal structure of M. tuberculosis inha inhibited by SKTS1”. X-ray diffraction, 4 ligands (NAD, F9T, NA), 2 pockets (best druggability 0.82). MolNFT v1 #171142 on GenesisL1: 3D…

PDB
6YUU
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
P9WGR0
Ligands
NAD, F9T, NA, CL
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26847% helix, 16% strandP9WGR0

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • F9T · 6-[4-(4-hexyl-2-oxidanyl-phenoxy)phenoxy]pyridin-2-ol · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15940.820.8756NAD, F9T
2950.440.7916empty

Compared structures

  • 6YUU · Crystal structure of M. tuberculosis InhA inhibited by SKTS1 · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WGR0 · AlphaFold monomer V2.0 prediction for enoyl-[acyl-carrier-protein] reductase [NADH]… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.